PATENT CLAIM ANALYSIS

Application Number: 16375404
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-07
Patent Classification: ["424", "400000"]

Abstract:
The present invention relates to a pharmaceutical composition for treating, preventing or improving premature ejaculation, which is taken on demand prior to sexual activity, the composition comprising clomipramine hydrochloride in an amount of 14 to 16 mg, preferably about 15 mg, as an active ingredient. More preferably, the composition of the present invention further comprises pregelatinized starch and sodium starch glycolate. The pharmaceutical composition of the present invention can provide rapid onset of efficacy, reduce a dissolution (absorption) deviation according to the patient's gastrointestinal pH conditions and minimize side effects.

Claim (Index 20):
The method of  claim 19 , wherein the pharmaceutical composition exhibits a dissolution rate of 90 wt % or more at 15 minutes of testing time in all of a buffer solution of pH 1.2, a buffer solution of pH 4.0, purified water and a buffer solution of pH 6.8 when the composition is subject to a dissolution test using a paddle and a 900 mL dissolution medium.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 100.0
- Lexical Diversity: 1.47143
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['09996407', '14463966', '10806072', '14463921', '14463959']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7481935774209799
- 35 USC 102 Novelty (BERT): 0.5058087544490688
- Combined Prediction Score: 0.7239550951237887
- Mean Citation Score: 197.894538
- Max Citation Score: 199.72098
- Similarity Product: 116.85514925066828

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test